Navigation Links
Two Regenstrief investigators receive NIH career development awards
Date:6/12/2014

INDIANAPOLIS -- Two Regenstrief Institute investigators and Indiana University Center for Aging Research scientists -- Michael LaMantia, M.D., MPH, and Noll L. Campbell, PharmD -- have each received five-year Mentored Patient-Oriented Research Career Development K23 Awards from the National Institute on Aging at the National Institutes of Health.

Dr. LaMantia is an assistant professor of medicine at the IU School of Medicine. His K23 award supports a project titled "DEEDS: Delirium Evaluation in the Emergency Department for Seniors."

Delirium affects approximately 10 percent of older adults who seek care in the emergency department, yet it is unrecognized in the majority of cases. To improve the care and management of older adults with delirium, it is critical to understand the dynamics that affect delirium recognition by emergency service providers. The goal of Dr. LaMantia's research is to determine the factors that influence delirium recognition and to discern those approaches to delirium assessment that are most associated with its identification. Dr. LaMantia reviewed the problem in a study published earlier this year in the Annals of Emergency Medicine.

Dr. Campbell is a research assistant professor in the Purdue University College of Pharmacy and a clinical pharmacy specialist in geriatrics with Eskenazi Health. His K23 career development award supports a project titled "Evaluating the Adverse Cognitive Effects of Medications."

This work continues his research into the role common medications play on cognition in older adults. A 2013 study by Dr. Campbell found that using anticholinergics -- which block the neurotransmitter acetylcholine -- for as few as 60 days causes memory problems in older adults. This award will further investigate the impact anticholinergics have on cognition and will also study the impact of statins and antihistamines.


'/>"/>
Contact: Cindy Fox Aisen
caisen@iupui.edu
317-843-2276
Indiana University
Source:Eurekalert  

Page: 1

Related medicine news :

1. IU, Regenstrief study: New noninvasive colorectal cancer screening tool highly accurate
2. Regenstrief, IU study: Half of hospitalized adults over 65 need surrogate decision-makers
3. Regenstrief and IU review finds lack of delirium screening in the emergency department
4. RSNA and Regenstrief Institute launch effort to unify radiology procedure naming
5. CHICA, automated system developed by Regenstrief and IU, improves autism screening rate
6. Regenstrief and IU study: Older adults with severe mental illness challenge healthcare system
7. IU, Regenstrief initiative aims to decrease hospitalization of nursing home residents
8. Regenstrief and IU study investigates older adults views on cancer screening
9. Regenstrief study: Informatics tools underutilized in prevention of hospital-acquired infection
10. Regenstrief investigator inducted into medical informatics honor society
11. Regenstrief study finds that generic drugs often have incorrect safety labeling
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Two Regenstrief investigators receive NIH career development awards
(Date:12/25/2014)... The short film “Color of Honor” by young ... a true 9/11 hero, Welles Remy Crowther. It has been ... hours of Nuremberg International Short Film Festival and the 8th ... screenwriter and director Luciana Lagana plays the mother of ... husband, Gregory Graham - Graham plays a heroic ...
(Date:12/25/2014)... California (PRWEB) December 25, 2014 Helen ... home in Woodland Hills, California after an 8 year ... away on Christmas Eve evening in her home in ... aggressive metastatic breast cancer. , As ... over forty years, she pioneered and championed many of ...
(Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. 24, 2014 (HealthDay ... receive effective, less expensive care from a clinic that functions ... of dedicated health care professionals, a new study shows. ... either hospitalization or a trip to the emergency room when ... the University of Texas in Houston versus usual care, according ...
(Date:12/25/2014)... News) -- Among early stage breast cancer patients who ... one percent will eventually develop leukemia as a result ... finding comes from a review of more than 20,000 ... it suggests that the risk for developing treatment-related leukemia, ... thought. "The frequency of bone marrow cancers such ...
(Date:12/25/2014)... Thousands of transvaginal mesh lawsuits ( ... number of multidistrict litigations currently underway in U.S. District ... reports. According to an Order issued on December 2, ... Status Conference in all of the proceedings on January ... to submit a proposed agenda to the Court by ...
Breaking Medicine News(10 mins):Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 4
... from the University of Georgia and the Mayo Clinic in ... a mouse model that mimics 90 percent of human breast ... treatments. The vaccine, described this week in ... National Academy of Sciences , reveals a promising new strategy ...
... Researchers from the University of Maryland School of Medicine and ... exercise and computerized memory training to see if those activities ... type of memory that will be examined is known as ... use it in a new way. Many Parkinson,s ...
... cancer cells, scientists at Johns Hopkins have found that a ... ability of pre-leukemic cells to repair broken bits of their ... their experiments, expected to be presented at the 53rd Annual ... Dec. 12, have already prompted clinical trials of the drugs ...
... finds that patients who are moved into isolation during a ... a potentially dangerous change in mental status that often affects ... not at increased risk. The study, published in the ... the journal of the Society for Healthcare Epidemiology of America, ...
... have discovered a new way to target cancer through manipulating ... The findings, published today [12 Dec] in the journal ... producing their own blood vessels. Cancer cells gain ... vessels grow, helping deliver oxygen and sugars to the tumour. ...
... MONDAY, Dec. 12 (HealthDay News) -- An advisory panel to the ... Evra birth control patch carries a higher risk of blood clots ... off drug store shelves. The panel, which based its decision ... 19 to 5 that the benefits of Johnson & Johnson,s Ortho ...
Cached Medicine News:Health News:Scientists develop vaccine that attacks breast cancer in mice 2Health News:Scientists develop vaccine that attacks breast cancer in mice 3Health News:Scientists develop vaccine that attacks breast cancer in mice 4Health News:Exercise/memory research for Parkinson's 2Health News:Exercise/memory research for Parkinson's 3Health News:'PARP' drug sabotages DNA repair in pre-leukemic cells 2Health News:'PARP' drug sabotages DNA repair in pre-leukemic cells 3Health News:Patient isolation associated with hospital delirium: study 2Health News:Scientists discover new way to target cancer 2Health News:FDA Panel Cites Clot Risk From Contraceptive Patch 2
(Date:12/24/2014)... 23, 2014 ResMed (NYSE: RMD ) ... against Chinese medical device manufacturer BMC Medical Co., Ltd. ... BMC,s masks listed below infringe ResMed,s patents, and entered an ... in the United States : ... , Willow nasal pillows mask , iVolve full ...
(Date:12/24/2014)... , Dec. 23, 2014  The American ... blood pressure target for people with diabetes and ... or high doses of statins, in keeping with ... enacted by the American College of Cardiology (ACC) ... reflected in the most recent changes to the ...
(Date:12/22/2014)... 2014  CytoSorbents Corporation (OTCQB:CTSOD), a critical care ... technology to help fight deadly inflammation in critically-ill ... today announced the appointment of Dr. Gregory ... Senior Vice President of Clinical Development, effective January ... Russo is an accomplished pediatric cardiothoracic surgeon ...
Breaking Medicine Technology:ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5
... 7, 2010 Where do you start when trying to ... ), an independent nonprofit that researches the best approaches to ... release of its 5th annual list of Top 10 ... free download with registration, the list features the ...
... Research Group (MRG), the global authority on medical technology ... the US clot management device market.   ... report provides important insight into the device-based treatments ... of medical device manufacturers in this field. The report ...
Cached Medicine Technology:ECRI Institute Releases 'Top 10 Health Technology Hazards for 2011' 2ECRI Institute Releases 'Top 10 Health Technology Hazards for 2011' 3Millennium Research Group to Release Their Latest US Clot Management Data 2
... purpose incubators designed to provide ... uniformity required for the most ... microprocessor controlled incubators feature push-button ... digital display, and built-in over-temperature ...
... available in five different models. Choose mechanical ... Ft. (39 liters), 2.5 cu. Ft. (71.5 ... Equally important, Precision Economy Incubators combine a ... stability, and uniformity. As a result, you ...
Aspheric diagnostic lens. 90D...
Binocular indirect ophthalmic lenses. General diagnosis & treatment....
Medicine Products: